The alleviated systemic inflammation leads to downregulation of ICAM-1, VCAM-1, and MMP-9 in the brain, which preserves the cerebral endothelial glycocalyx and protects the BBB, resulting in protection against stroke injury. Here, MMP9 is linked to stroke disorder.